LAURUS LABS LIMITED vs Q-LINE BIOTECH LIMITED
A side-by-side comparison of LAURUS LABS LIMITED (LAURUSLABS) and Q-LINE BIOTECH LIMITED (QLINE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, Q-LINE BIOTECH LIMITED leads LAURUSLABS vs QLINE on 9 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation13
- Profitability04
- Growth02
- Size & financial health40
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
QLINE takes 3/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
QLINE takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
QLINE takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
LAURUSLABS takes 4/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + []
- − ["Stock is trading at 21.09 times its book value", "The company has delivered a poor sales growth of 7.2% over past five years.", "The company has delivered a poor profit growth of -2.0% over past five years."]
- + ["Company has a good return on equity (ROE) track record: 3 Years ROE 21.7%"]
- − ["Stock is trading at 5.70 times its book value", "Though the company is reporting repeated profits, it is not paying out dividend"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.